Dyne Therapeutics grants inducement equity awards for 475,100 shares to 12 new hires

Dyne Therapeutics granted inducement equity awards to 12 new hires under its 2024 Inducement Stock Incentive Plan.

• Non-statutory stock options cover 358,600 shares and were priced at the July 21 Nasdaq closing price; the options run for 10 years.
• The options vest over four years: 25% after one year, then quarterly.
• Restricted stock units cover 116,500 shares and vest annually over four years.